Howarth Alex G. — SEC insider filings
SEC reporting owner CIK 1795798. 9 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2020-10-13 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Chief Financial Officer | 6 | — | — | 8 |
| AKCEA THERAPEUTICS, INC. (AKCA) | Chief Operating Officer | 1 | — | — | 3 |
| Altimmune, Inc. (ALT) | Director | 2 | — | — | 1 |
Insider filings — Howarth Alex G.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 3 | Altimmune, Inc. (ALT) | Holdings only — no transactions reported | EDGAR |
| 2026-11-04 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 4,803 @ $0 · Grant/award (A): 7,238 (derivative) @ $0 · Grant/award (A): 4,803 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Tax withholding (F): 1,067 @ $243.92 | EDGAR |
| 2023-01-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 15,001 @ $0 | EDGAR |
| 2022-02-24 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2021-11-03 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2021-05-19 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2020-10-13 | 4 | AKCEA THERAPEUTICS, INC. (AKCA) | Code (U): 66,800 @ $18.15 · Disposition to issuer (D): 300,000 (derivative) @ $0.21 · Disposition to issuer (D): 34,200 (derivative) @ $5.39 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1795798 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs